About the Medical Retina and Macular Diseases Session
Medical Retina and Macular Diseases focuses on disorders affecting the retina, macula, and choroid that are primarily managed through medical, pharmacological, or non-surgical approaches. Topics include age-related macular degeneration, diabetic retinal disease, vascular disorders, macular conditions, retinal degeneration, multimodal imaging, and emerging retinal therapies.
Abstract Scope and Participation
Abstracts may address retinal disease mechanisms, imaging, diagnostics, pharmacological treatments, intravitreal therapies, clinical trials, biomarkers, disease progression, and treatment outcomes. Retina specialists, ophthalmologists, researchers, imaging experts, vision scientists, and professionals involved in retinal therapeutics are invited to contribute.
Topics Covered in Medical Retina and Macular Diseases
Topic 01
Macular Degeneration
Topic 02
Diabetic Retinopathy
Topic 03
Retinal Vascular Diseases
Topic 04
Macular Disorders
Topic 05
Retinal Degeneration
Topic 06
Retinal Therapies
Featured Speakers — Medical Retina and Macular Diseases 2027
Karishma Parmar
Birmingham Midland Eye Centre
Atypical central retinal vein occlusion in a young healthy adult
Recent Research Presented at Medical Retina and Macular Diseases Sessions
Stereotactic radiotherapy for wet age-related macular degeneration: year 4 results of a randomised, double-masked, sham-controlled trial
Aim: To investigate the long term, real-world safety and efficacy of Stereotactic Radiotherapy (SRT) for exudative Age-Related Macular Degeneration (AMD). Methods: This randomised, double-masked…
A double hit to the macula: Staging hypertension's impact on diabetic macular edema via Optical Coherence Tomography
Introduction: Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia resulting from impaired insulin secretion, insulin action, or both. Among ocular…
Atypical central retinal vein occlusion in a young healthy adult
Case presentation: A young male presented with a two-month history of blurred vision in his right eye. Assessment demonstrated Visual Acuity (VA) of 6/9, markedly reduced colour vision (1/17 Ishihara…
Correlation of choroidal thickness and c-reactive protein levels in patients with age-related macular degeneration
Age-Related Macular Degeneration (AMD) is a major cause of irreversible vision loss in the elderly population. Its pathogenesis is multifactorial, with inflammation and vascular changes playing…
Beyond fluid resolution: Long-term real-world retinal biomarker evolution following faricimab for treatment-naïve diabetic macular oedema
Purpose : To characterise longitudinal changes in retinal biomarkers following faricimab treatment in treatment-naïve diabetic macular oedema (DMO), evaluate associated visual, anatomical and…
Effects of intravitreal implantation of ranibizumab combined with dexamethasone on VEGFs ILs and clinical efficacy in patients with BRVO ME
Objective : To investigate the effect of intravitreal implant of ranibizumab combined with dexamethasone on Vascular Endothelial Growth Factors (VEGFs), Interleukins (ILs) and clinical efficacy in…
Related Scientific Sessions at IOC 2027
Why Attend the Medical Retina and Macular Diseases Conference 2027
Earn CPD Credit
Sessions are CPD-accredited by The CPD Group (UK) — one CPD credit for every hour of attendance.
Present Your Research
Oral and poster slots for original Medical Retina and Macular Diseases work, reviewed by the scientific committee.
Network Globally
Meet ophthalmologists, vision scientists, and eye-care clinicians from around the world across three days.
Publish & Get Indexed
Accepted abstracts are compiled into the conference proceedings and indexed in Scopus and Web of Science.
Learn from Keynotes
Plenary lectures from leading voices shaping Medical Retina and Macular Diseases research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join IOC 2027 for the Medical Retina and Macular Diseases track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Medical Retina and Macular Diseases Conference 2027 — FAQs
What is the Medical Retina and Macular Diseases track at IOC 2027?
The Medical Retina and Macular Diseases track is a dedicated stream within IOC 2027 covering the latest research, clinical innovation, and best practice in Medical Retina and Macular Diseases. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Medical Retina and Macular Diseases sessions?
Ophthalmologists, optometrists, vision scientists, educators, doctoral students, and trainees with an interest in Medical Retina and Macular Diseases are all welcome — whether presenting or attending.
Can I present my research in the Medical Retina and Macular Diseases track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Medical Retina and Macular Diseases sessions?
Yes. IOC 2027 is a hybrid conference — attend the Medical Retina and Macular Diseases track in person in Singapore or join live online, with on-demand access afterward.
Join the IOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Register as Delegate →
Attend without presenting.